Phospholipid

Optimal result: 0.4 – 1.7 ELISA Index

Antibodies against phospholipids may have an important role in mediating platelet destruction in autoimmune disorders. Anti-phospholipid antibodies (anti-PL) have been shown to bind to the membrane of activated platelets; thus it has been postulated that this may result in increased destruction of platelets by the reticuloendothelial system. [3]

Anti-PL have been demonstrated in patients with autoimmune thrombocytopenia (AITP) and Systemic lupus erythematosus (SLE). [3]

Anti-PL are directed against a diverse group of phospholipids and phospholipid-binding proteins; among these, anti-cardiolipin (anti-CL), anti-beta-2-glycoprotein I (b2-GP-I) and anti-prothrombin antibodies seem to be the most relevant from the clinical viewpoint. [1]

Anti-PL have been found in moderate and severe noninsulin-dependent diabetes mellitus patients, and thus may suggest that autoimmune nerve destruction may be involved in diabetic neuropathy in NIDDM patients. [7]

Anti-phospholipid antibody syndrome may appear as a stand-alone syndrome or associated with major connective tissue disease such as SLE and may manifest in a number of neurological conditions. [1]

Widespread thrombosis and infarction of placentas obtained from women with antiphospholipid syndrome (APS) was actually reported both in first and second trimester abortions. [4] There is evidence from in vitro studies that anti-PL may induce pro-coagulant state at the placental level, thus playing a pathogenic role of thrombotic events in anti-PL-associated pregnancy. [4]

It can be concluded that impaired endothelial fibrinolysis is a potential prothrombotic mechanism in subjects with antiphospholipid antibodies. [5]

Function:

Phospholipids are a class of lipids that are a major component of all cell membranes. They play a role in the formation of lipid bilayers. Most phospholipids contain a diglyceride, a phosphate group, and a simple organic molecule such as choline.

Antibodies Appear:

- Antiphospholipid Syndrome[1, 4]

- NIDDM [7]

- Systemic Lupus Erythematosus [3, 6]

Known Cross-Reactions:

- Anti-ribosomal P protein antibodies [1]

- DNA [2]

- Cardiolipin [2]

Function:

Phospholipids are a class of lipids that are a major component of all cell membranes. They play a role in the formation of lipid bilayers. Most phospholipids contain a diglyceride, a phosphate group, and a simple organic molecule such as choline.

Antibodies Appear:

- Antiphospholipid Syndrome[1, 4]

- NIDDM [7]

- Systemic Lupus Erythematosus [3, 6]

Known Cross-Reactions:

- Anti-ribosomal P protein antibodies [1]

- DNA [2]

- Cardiolipin [2]

Clinical Significance:

Antibodies against phospholipids may have an important role in mediating platelet destruction in autoimmune disorders. Anti-phospholipid antibodies (anti-PL) have been shown to bind to the membrane of activated platelets; thus it has been postulated that this may result in increased destruction of platelets by the reticuloendothelial system. [3]

Anti-PL have been demonstrated in patients with autoimmune thrombocytopenia (AITP) and Systemic lupus erythematosus (SLE). [3]

Anti-PL are directed against a diverse group of phospholipids and phospholipid-binding proteins; among these, anti-cardiolipin (anti-CL), anti-beta-2-glycoprotein I (b2-GP-I) and anti-prothrombin antibodies seem to be the most relevant from the clinical viewpoint. [1]

Anti-PL have been found in moderate and severe noninsulin-dependent diabetes mellitus patients, and thus may suggest that autoimmune nerve destruction may be involved in diabetic neuropathy in NIDDM patients. [7]

Anti-phospholipid antibody syndrome may appear as a stand-alone syndrome or associated with major connective tissue disease such as SLE and may manifest in a number of neurological conditions. [1]

Widespread thrombosis and infarction of placentas obtained from women with antiphospholipid syndrome (APS) was actually reported both in first and second trimester abortions. [4] There is evidence from in vitro studies that anti-PL may induce pro-coagulant state at the placental level, thus playing a pathogenic role of thrombotic events in anti-PL-associated pregnancy. [4]

It can be concluded that impaired endothelial fibrinolysis is a potential prothrombotic mechanism in subjects with antiphospholipid antibodies. [5]

References:

1. Caponi, et al. Antibodies directed against ribosomal P proteins cross-react with phospholipids. Clin exp Immunol, 2007; 150:140–143.

2. Koike, et al. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin exp Immunol, 1982; 50:298-302.

3. Lipp, et al. Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia. Eur J Haemotol, 1998; 60:283-288.

4. Meroni, et al. Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view. Lupus, 2010; 19:453-456.

5. Patterson, et al. The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells. Br J Haematol, 2006; 133:323–330.

6. Petri. Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort. Lupus, 2010; 19:419-423.

7. Shigeta, et al. Serum Autoantibodies Against Sulfatide and Phospholipid in NIDDM Patients With Diabetic Neuropathy. Diabetes Care, 1997; 20(12): 1896-1899.

Phospholipid
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Phospholipid — 10,000+ markers explained
One Phospholipid result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro